BioPharma Dive September 24, 2024
Alicia Zhou, the new head of the nonprofit Cancer Research Institute, wants to foster deeper partnerships between scientists and the pharmaceutical indus
Less than a month into her role as CEO of the nonprofit Cancer Research Institute, Alicia Zhou has some big ideas for the future of the organization.
The CRI has funded cutting-edge oncology research, primarily in the field of immunotherapy, since 1953, when the approach was considered experimental and unorthodox. Cut to present day and immuno-oncology has become a major pillar in cancer treatment and research, resulting in some of the world’s best-selling medicines.
And Zhou sees more opportunities for evolution in the field, as well as CRI’s role in encouraging and establishing routes of partnership between...
Today's Sponsors
Today's Sponsor